Trial Profile
A Pharmacodynamic Pre-surgical Study of Hedgehog Pathway Inhibition With LDE225 in Men With High-risk Localized Prostate Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sonidegib (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Pharmacodynamics
- 26 Apr 2017 Status changed from recruiting to completed.
- 05 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 29 Apr 2014 New trial record